152 related articles for article (PubMed ID: 15962832)
1. Antidementia agents: what is important in this class.
Stefanacci RG; Cafiero AC
Manag Care; 2005 May; 14(5 Suppl):11-6. PubMed ID: 15962832
[No Abstract] [Full Text] [Related]
2. The P&T Society.
Bootman L
Manag Care Interface; 2006 Feb; 19(2):13, 15. PubMed ID: 16583504
[No Abstract] [Full Text] [Related]
3. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
[No Abstract] [Full Text] [Related]
4. I remember.
Ladouceur R
Can Fam Physician; 2006 Feb; 52():155. PubMed ID: 16529383
[No Abstract] [Full Text] [Related]
5. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
[TBL] [Abstract][Full Text] [Related]
6. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease.
Rabins PV; Lyketsos CG
Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739
[No Abstract] [Full Text] [Related]
7. Harmonisation of availability of drugs for Alzheimer's disease.
Winblad B
Lancet; 1999 Jul; 354(9174):257. PubMed ID: 10421337
[No Abstract] [Full Text] [Related]
8. [New options for the pharmacotherapy of Alzheimer disease after the approval of memantine? Re the article from DMW 8/2005].
Wellhöfer B
Dtsch Med Wochenschr; 2006 Feb; 131(6):284. PubMed ID: 16463237
[No Abstract] [Full Text] [Related]
9. Nationwide use of medicines for Alzheimer's disease by community-dwelling persons in Finland.
Alander J; Lönnroos E; Hartikainen S; Klaukka T
J Am Geriatr Soc; 2006 Mar; 54(3):557-8. PubMed ID: 16551340
[No Abstract] [Full Text] [Related]
10. Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study.
Koller D; Hua T; Bynum JP
J Am Geriatr Soc; 2016 Aug; 64(8):1540-8. PubMed ID: 27341454
[TBL] [Abstract][Full Text] [Related]
11. I why we need a PDL and how it works.
Hauser H
Tex Med; 2004 Apr; 100(4):7. PubMed ID: 15303483
[No Abstract] [Full Text] [Related]
12. Drugs for Alzheimer disease.
Can Fam Physician; 2005 Nov; 51(11):1485. PubMed ID: 16353830
[No Abstract] [Full Text] [Related]
13. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Tariot PN
J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of current Alzheimer's disease treatments: a descriptive review.
Cummings JL; Mackell J; Kaufer D
Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950
[TBL] [Abstract][Full Text] [Related]
15. Do P&T committees have enough power? Plans and PBMs are divided about sharing drug prices with clinicians. Is it better to have an administrative committee determine the formulary?
Cross M
Manag Care; 2007 Apr; 16(4):39-42. PubMed ID: 17491288
[No Abstract] [Full Text] [Related]
16. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Beier MT
Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
[TBL] [Abstract][Full Text] [Related]
17. Plans, PBMs, pharmacy jockey for part D positioning. Are pharmacies raising rates for health plans?
Med Health; 2005 Jun; 59(20):1-2. PubMed ID: 16021969
[No Abstract] [Full Text] [Related]
18. Incidence of cholinergic and memantine treatment in Alzheimer's disease in Finland.
Virta L; Viramo P
J Am Geriatr Soc; 2007 Nov; 55(11):1886-7. PubMed ID: 17979907
[No Abstract] [Full Text] [Related]
19. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
Lu S; Hill J; Fillit H
Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
[TBL] [Abstract][Full Text] [Related]
20. Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries.
Gruber-Baldini AL; Stuart B; Zuckerman IH; Simoni-Wastila L; Miller R
J Am Geriatr Soc; 2007 Oct; 55(10):1508-16. PubMed ID: 17727648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
